Incannex Financial Statements From 2010 to 2026

IXHL Stock  USD 0.41  0.01  2.50%   
Incannex Healthcare's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Incannex Healthcare's valuation are provided below:
Gross Profit
12 K
Market Capitalization
140.4 M
Enterprise Value Revenue
5.4 K
Revenue
12 K
Earnings Share
(1.08)
There are over one hundred nineteen available fundamental trends for Incannex Healthcare, which can be analyzed over time and compared to other ratios. We recommend to confirm Incannex Healthcare's regular fundamental drivers against the all of the trends between 2010 and 2026. The value of Market Cap is estimated to slide to about 6.4 M. Enterprise Value is expected to rise to about (6.3 M) this year

Incannex Healthcare Total Revenue

93,955

Check Incannex Healthcare financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Incannex Healthcare's main balance sheet or income statement drivers, such as Depreciation And Amortization of 486.7 K, Interest Expense of 365.9 K or Gross Profit of 86.7 K, as well as many indicators such as Price To Sales Ratio of 94.41, Dividend Yield of 0.0 or PTB Ratio of 0.67. Incannex financial statements analysis is a perfect complement when working with Incannex Healthcare Valuation or Volatility modules.
  
Build AI portfolio with Incannex Stock
Check out the analysis of Incannex Healthcare Correlation against competitors.

Incannex Healthcare Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets12 M23.5 M11.2 M
Slightly volatile
Short and Long Term Debt Total220.6 K232.2 K532.9 K
Slightly volatile
Other Current Liabilities821.7 K834.9 K888 K
Pretty Stable
Total Current Liabilities8.4 MM2.7 M
Slightly volatile
Cash And Short Term Investments18.2 M17.3 M6.8 M
Slightly volatile
Net Receivables5.6 M5.3 M1.7 M
Slightly volatile
Common Stock Shares Outstanding47.3 M39.6 M54.9 M
Very volatile
Liabilities And Stockholders Equity12 M23.5 M11.2 M
Slightly volatile
Other Current Assets392.8 K341.6 K416.7 K
Very volatile
Total Liabilities8.5 M8.1 M3.4 M
Slightly volatile
Total Current Assets24.1 M23 M8.9 M
Slightly volatile
Short Term Debt313.8 K165.6 K374.8 K
Slightly volatile
Common Stock21.9 K23 K17.2 M
Slightly volatile
Accounts Payable7.3 MM1.5 M
Slightly volatile
Cash18.2 M17.3 M7.1 M
Slightly volatile
Other Assets0.80.90.9824
Slightly volatile
Other Stockholder Equity210.2 M200.2 M49.1 M
Slightly volatile
Short Term Investments215.5 K149.9 K166.1 K
Very volatile
Current Deferred Revenue82.9 K97.8 K66.1 K
Slightly volatile
Intangible Assets42.4 M40.4 M17.3 M
Slightly volatile
Short and Long Term Debt106 K58.5 K130.6 K
Slightly volatile
Property Plant Equipment1.4 M1.4 M634.7 K
Slightly volatile
Capital Stock2.2 K2.3 K35.3 M
Very volatile

Incannex Healthcare Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization486.7 K282.9 K554.7 K
Pretty Stable
Interest Expense365.9 K348.4 K125.5 K
Slightly volatile
Other Operating Expenses28.8 M27.5 M12.2 M
Slightly volatile
Cost Of Revenue88.1 K92.7 K316.1 K
Slightly volatile
Selling General Administrative15.4 M14.6 M5.6 M
Slightly volatile
Total Revenue94 K98.9 K369.3 K
Pretty Stable
Selling And Marketing Expenses426.1 K448.5 K558.8 K
Slightly volatile
Interest Income248.7 K236.9 K78.4 K
Slightly volatile
Research Development7.3 M12.4 M4.1 M
Slightly volatile

Incannex Healthcare Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow4.2 M6.7 M4.5 M
Slightly volatile
Depreciation268.8 K282.9 K912.9 K
Very volatile
Capital Expenditures6.8 K7.2 K152.4 K
Slightly volatile
End Period Cash Flow18.2 M17.3 M7.1 M
Slightly volatile
Stock Based Compensation1.9 MM1.3 M
Slightly volatile
Change To Netincome1.8 M3.7 M1.3 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio94.4199.385.1 K
Slightly volatile
Days Sales Outstanding19.5 K17.7 K40.4 K
Slightly volatile
Average Payables209.7 K301.3 K264.6 K
Slightly volatile
Stock Based Compensation To Revenue25.9427.392.9092
Slightly volatile
Capex To Depreciation0.03550.03743.2786
Slightly volatile
Inventory Turnover2.182.212.4256
Very volatile
Days Of Inventory On Hand154171152
Pretty Stable
Payables Turnover0.00420.00440.8267
Slightly volatile
Sales General And Administrative To Revenue129133268
Slightly volatile
Average Inventory160.2 K152.5 K114.5 K
Slightly volatile
Research And Ddevelopement To Revenue107112211
Slightly volatile
Capex To Revenue0.10.114.1074
Very volatile
Cash Per Share0.410.390.2263
Slightly volatile
Days Payables Outstanding71.1 K67.7 K26.1 K
Slightly volatile
Intangibles To Total Assets0.10.110.2752
Slightly volatile
Current Ratio5.623.293.8511
Slightly volatile
Receivables Turnover0.02030.021415.4677
Slightly volatile
Capex Per Share3.0E-43.0E-40.0129
Slightly volatile
Average Receivables166.6 K235.9 K200.8 K
Pretty Stable
Revenue Per Share0.00270.00290.0051
Slightly volatile
Interest Debt Per Share0.01780.01870.0694
Slightly volatile
Debt To Assets0.01080.01140.2124
Pretty Stable
Graham Number7.268.178.9132
Slightly volatile
Operating Cycle19.5 K17.7 K40.5 K
Slightly volatile
Days Of Payables Outstanding71.1 K67.7 K26.1 K
Slightly volatile
Ebt Per Ebit0.91.771.3211
Pretty Stable
Long Term Debt To Capitalization1.641.561.3686
Slightly volatile
Quick Ratio5.573.293.786
Slightly volatile
Net Income Per E B T0.780.90.9598
Very volatile
Cash Ratio2.491.943.1654
Slightly volatile
Days Of Inventory Outstanding154171152
Pretty Stable
Days Of Sales Outstanding19.5 K17.7 K40.4 K
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.181.151.0408
Slightly volatile
Fixed Asset Turnover0.150.162.9569
Slightly volatile
Debt Ratio0.01080.01140.2124
Pretty Stable
Price Sales Ratio94.4199.385.1 K
Slightly volatile
Asset Turnover0.00360.00380.3049
Very volatile

Incannex Healthcare Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap6.4 M6.7 M73.8 M
Slightly volatile

Incannex Fundamental Market Drivers

About Incannex Healthcare Financial Statements

Incannex Healthcare investors utilize fundamental indicators, such as revenue or net income, to predict how Incannex Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue97.8 K82.9 K
Cost Of Revenue92.7 K88.1 K
Total Revenue98.9 K94 K
Stock Based Compensation To Revenue 27.30  25.94 
Sales General And Administrative To Revenue 133.30  128.61 
Research And Ddevelopement To Revenue 112.47  106.85 
Capex To Revenue 0.11  0.10 
Ebit Per Revenue(318.11)(334.01)

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Prophet
When determining whether Incannex Healthcare is a strong investment it is important to analyze Incannex Healthcare's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Incannex Healthcare's future performance. For an informed investment choice regarding Incannex Stock, refer to the following important reports:
Check out the analysis of Incannex Healthcare Correlation against competitors.
You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Incannex Healthcare. If investors know Incannex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Incannex Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.08)
Quarterly Revenue Growth
(1.00)
Return On Assets
(0.30)
Return On Equity
(1.15)
The market value of Incannex Healthcare is measured differently than its book value, which is the value of Incannex that is recorded on the company's balance sheet. Investors also form their own opinion of Incannex Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Incannex Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Incannex Healthcare's market value can be influenced by many factors that don't directly affect Incannex Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Incannex Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Incannex Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Incannex Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.